Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

2(40.0%)

5Total

N/A(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT05633784Not ApplicableCompleted

Telemedicine Home-based Management in Patients With CHF and Type 2 Diabetes

Role: collaborator

NCT04898179Completed

Support for COVID19 Patients at Home

Role: collaborator

NCT03041727Not ApplicableCompleted

Physiotherapist Approach to Shoulder's Diseases, Differences Between Fascial Manipulation and Standard Exercises

Role: lead

NCT04327323Unknown

CCM Italian Registry

Role: collaborator

NCT02601781Phase 4Unknown

Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry

Role: lead

NCT02750839Unknown

Influence of Osteoporosis on Clinical Outcomes of Mini-invasive Surgical Treatment of Proximal Humerus Fractures

Role: lead

NCT02750852Unknown

An Algorithm for Predicting Blood Loss and Transfusion Risk in Fast Track Total Hip Arthroplasty

Role: lead

NCT02645435Phase 4Completed

Consequence of the Learning Curve in Direct Anterior Approach for Total Hip Replacement

Role: lead

NCT02442518Unknown

Antenatal Diagnosis of Placental Attachment Disorders

Role: collaborator

NCT02576028Not ApplicableCompleted

Fascial Manipulation® Associated With Standard Care Versus Standard Post-surgical Care for Total Hip Arthroplasty

Role: lead

All 10 trials loaded